MIT engineers have developed a method for mass-producing cell-sized graphene-based robots. The new method involves precisely controlling the fracture pattern on the graphene microplate prior to manufacturing. These robots could be used to diagnose disease while inside the bloodstream.


Previous articleAlexion, Dicerna Launch $637M+ RNAi Collaboration in Complement-Mediated Diseases
Next articleBreast Cancer Immunotherapy Delivered without Side Effects